GP Act Valuation
| GPAT Stock | 10.11 0.03 0.30% |
At this time, the firm appears to be fairly valued. GP Act III owns a latest Real Value of USD9.88 per share. The recent price of the firm is USD10.11. Our model calculates the value of GP Act III from inspecting the firm fundamentals such as Number Of Shares Shorted of 3.41 K, shares outstanding of 28.75 M, and Net Income of (14.04 K) as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GP Act's valuation include:
Price Book 1.2961 | Enterprise Value 362.1 M | Trailing PE 67.2 |
Fairly Valued
Today
Please note that GP Act's price fluctuation is very steady at this time. Calculation of the real value of GP Act III is based on 3 months time horizon. Increasing GP Act's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
GP Act's intrinsic value may or may not be the same as its current market price of 10.11, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.11 | Real 9.88 | Hype 10.11 | Naive 10.08 |
The intrinsic value of GP Act's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GP Act's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GP Act III Acquisition helps investors to forecast how GPAT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GP Act more accurately as focusing exclusively on GP Act's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GP Act's intrinsic value based on its ongoing forecasts of GP Act's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GP Act's closest peers.
GPAT Valuation Trend
GP Act's real value is important for investors to make better decisions and a more accurate overall view of GP Act's financial worth over time. Using both GP Act's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
GPAT Valuation Data Drivers
GP Act Total Value Analysis
GP Act III Acquisition is currently forecasted to have valuation of 362.14 M with market capitalization of 362.25 M, debt of 628.18 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GP Act fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
362.14 M | 362.25 M | 628.18 K |
GP Act Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of GPAT implies not a very effective usage of assets in November.GP Act Ownership Allocation
GP Act III secures a total of 28.75 Million outstanding shares. 30% of GP Act III outstanding shares are owned by institutions. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Hence, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.GP Act Profitability Analysis
Net Loss for the year was (14.04 K) with profit before overhead, payroll, taxes, and interest of 0.About GP Act Valuation
The stock valuation mechanism determines GP Act's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of GP Act III based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of GP Act. We calculate exposure to GP Act's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GP Act's related companies.GP Act Growth Indicators
Investing in growth stocks can be very risky. If the company such as GP Act does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 31.2 M |
GP Act Current Valuation Indicators
GP Act's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final GP Act's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GP Act, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GP Act's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GP Act's worth.Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.